145 related articles for article (PubMed ID: 33509851)
1. Postneoadjuvant surveillance and surgery as needed compared with postneoadjuvant surgery on principle in multimodal treatment for oesophageal cancer: a scoping review protocol.
Schmucker C; Nagavci B; Hipp J; Schmoor C; Meerpohl J; Hoeppner J
BMJ Open; 2021 Jan; 11(1):e044190. PubMed ID: 33509851
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.
Noordman BJ; Wijnhoven BPL; Lagarde SM; Boonstra JJ; Coene PPLO; Dekker JWT; Doukas M; van der Gaast A; Heisterkamp J; Kouwenhoven EA; Nieuwenhuijzen GAP; Pierie JEN; Rosman C; van Sandick JW; van der Sangen MJC; Sosef MN; Spaander MCW; Valkema R; van der Zaag ES; Steyerberg EW; van Lanschot JJB;
BMC Cancer; 2018 Feb; 18(1):142. PubMed ID: 29409469
[TBL] [Abstract][Full Text] [Related]
4. Proximal gastrectomy and double-tract reconstruction vs total gastrectomy in gastric and gastro-esophageal junction cancer patients - a systematic review and meta-analysis protocol (PROSPERO registration number: CRD42021291500).
Hipp J; Kuvendjiska J; Martini V; Hillebrecht HC; Fichtner-Feigl S; Diener MK
Syst Rev; 2023 Aug; 12(1):150. PubMed ID: 37644614
[TBL] [Abstract][Full Text] [Related]
5. Perfusion parameters and target values during extracorporeal cardiopulmonary resuscitation: a scoping review protocol.
Saemann L; Schmucker C; Rösner L; Beyersdorf F; Benk C
BMJ Open; 2019 Aug; 9(8):e030562. PubMed ID: 31473622
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopically assisted versus open oesophagectomy for patients with oesophageal cancer-the Randomised Oesophagectomy: Minimally Invasive or Open (ROMIO) study: protocol for a randomised controlled trial (RCT).
Brierley RC; Gaunt D; Metcalfe C; Blazeby JM; Blencowe NS; Jepson M; Berrisford RG; Avery KNL; Hollingworth W; Rice CT; Moure-Fernandez A; Wong N; Nicklin J; Skilton A; Boddy A; Byrne JP; Underwood T; Vohra R; Catton JA; Pursnani K; Melhado R; Alkhaffaf B; Krysztopik R; Lamb P; Culliford L; Rogers C; Howes B; Chalmers K; Cousins S; Elliott J; Donovan J; Heys R; Wickens RA; Wilkerson P; Hollowood A; Streets C; Titcomb D; Humphreys ML; Wheatley T; Sanders G; Ariyarathenam A; Kelly J; Noble F; Couper G; Skipworth RJE; Deans C; Ubhi S; Williams R; Bowrey D; Exon D; Turner P; Daya Shetty V; Chaparala R; Akhtar K; Farooq N; Parsons SL; Welch NT; Houlihan RJ; Smith J; Schranz R; Rea N; Cooke J; Williams A; Hindmarsh C; Maitland S; Howie L; Barham CP
BMJ Open; 2019 Nov; 9(11):e030907. PubMed ID: 31748296
[TBL] [Abstract][Full Text] [Related]
8. Right versus left thoracic approach oesophagectomy for oesophageal cancer: a systematic review and meta-analysis protocol.
Chai T; Shen Z; Chen S; Lin Y; Zhang Z; Lin W; Hong J; Yang C; Kang M; Lin J
BMJ Open; 2019 Jul; 9(7):e030157. PubMed ID: 31289096
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer.
Gurusamy KS; Pallari E; Midya S; Mughal M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011390. PubMed ID: 27030301
[TBL] [Abstract][Full Text] [Related]
10. Health-related preferences of older patients with multimorbidity: the protocol for an evidence map.
González-González AI; Schmucker C; Blom J; van den Akker M; Nguyen TS; Nothacker J; Meerpohl JJ; Röttger K; Wegwarth O; Hoffmann T; Straus SE; Gerlach FM; Muth C
BMJ Open; 2019 Sep; 9(9):e029724. PubMed ID: 31481558
[TBL] [Abstract][Full Text] [Related]
11. Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial.
Mu J; Gao S; Mao Y; Xue Q; Yuan Z; Li N; Su K; Yang K; Lv F; Qiu B; Liu D; Chen K; Li H; Yan T; Han Y; Du M; Xu R; Wen Z; Wang W; Shi M; Xu Q; Xu S; He J
BMJ Open; 2015 Nov; 5(11):e008328. PubMed ID: 26576807
[TBL] [Abstract][Full Text] [Related]
12. Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer.
Eyck BM; van der Wilk BJ; Noordman BJ; Wijnhoven BPL; Lagarde SM; Hartgrink HH; Coene PPLO; Dekker JWT; Doukas M; van der Gaast A; Heisterkamp J; Kouwenhoven EA; Nieuwenhuijzen GAP; Pierie JEN; Rosman C; van Sandick JW; van der Sangen MJC; Sosef MN; van der Zaag ES; Spaander MCW; Valkema R; Lingsma HF; Steyerberg EW; van Lanschot JJB;
Trials; 2021 May; 22(1):345. PubMed ID: 34001287
[TBL] [Abstract][Full Text] [Related]
13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
14. Post-Neoadjuvant Surveillance and Surgery as Needed Compared with Post-Neoadjuvant Surgery on Principle in Multimodal Treatment for Esophageal Cancer: A Scoping Review.
Hipp J; Nagavci B; Schmoor C; Meerpohl J; Hoeppner J; Schmucker C
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33561090
[TBL] [Abstract][Full Text] [Related]
15. Patient-centered outcomes for gastrointestinal cancer care: a scoping review protocol.
Yang J; Barabash T; Rajendran L; Mahar AL; Hsu AT; James PD; Gotlib Conn L; Wright FC; Ludwig C; Kosyachkova E; Deleemans J; Coburn NG; Hallet J
BMJ Open; 2022 Jun; 12(6):e061309. PubMed ID: 35701055
[TBL] [Abstract][Full Text] [Related]
16. Overall morbidity after total minimally invasive keyhole oesophagectomy versus hybrid oesophagectomy (the MICkey trial): study protocol for a multicentre randomized controlled trial.
Klotz R; Diener MK; Schmidt T; Hackert T; Graf S; Fuchs HF; Grimminger P; Egberts JH; Gockel I; van der Sluis PC; Doerr-Harim C; Klose C; Feißt M; Mihaljevic AL
Trials; 2023 Mar; 24(1):175. PubMed ID: 36899404
[TBL] [Abstract][Full Text] [Related]
17. Comparing open and minimally invasive surgical procedures for oesophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial.
Metcalfe C; Avery K; Berrisford R; Barham P; Noble SM; Fernandez AM; Hanna G; Goldin R; Elliott J; Wheatley T; Sanders G; Hollowood A; Falk S; Titcomb D; Streets C; Donovan JL; Blazeby JM
Health Technol Assess; 2016 Jun; 20(48):1-68. PubMed ID: 27373720
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiation versus oesophagectomy for locally advanced oesophageal cancer in Chinese patients: study protocol for a randomised controlled trial.
Jia R; Yin W; Li S; Li R; Yang J; Shan T; Zhou D; Wang W; Wan L; Zhou F; Gao S
Trials; 2019 Apr; 20(1):206. PubMed ID: 30971301
[TBL] [Abstract][Full Text] [Related]
20. A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
Larue RT; Van De Voorde L; Berbée M; van Elmpt WJ; Dubois LJ; Panth KM; Peeters SG; Claessens A; Schreurs WM; Nap M; Warmerdam FA; Erdkamp FL; Sosef MN; Lambin P
BMC Cancer; 2016 Aug; 16():644. PubMed ID: 27535748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
